VCEL FY 2016 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M+6.3% YoY

Gross Profit

$26M47.9% margin

Operating Income

-$19M-35.4% margin

Net Income

-$20M-36.0% margin

EPS (Diluted)

$-0.85

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$49M

Total Liabilities

$24M

Stockholders' Equity

$25M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$51M	+6.3%
Gross Profit	$26M	$25M	+5.6%
Operating Income	-$19M	-$17M	-15.4%
Net Income	-$20M	-$16M	-19.7%